Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 152

1.

Mucosal healing in inflammatory bowel diseases: a systematic review.

Neurath MF, Travis SP.

Gut. 2012 Nov;61(11):1619-35. Epub 2012 Jul 27. Review.

PMID:
22842618
2.

Association between pharmacokinetics of adalimumab and mucosal healing in patients with inflammatory bowel diseases.

Roblin X, Marotte H, Rinaudo M, Del Tedesco E, Moreau A, Phelip JM, Genin C, Peyrin-Biroulet L, Paul S.

Clin Gastroenterol Hepatol. 2014 Jan;12(1):80-84.e2. doi: 10.1016/j.cgh.2013.07.010. Epub 2013 Jul 23.

PMID:
23891927
3.

Mucosal healing in the era of biologic agents in treatment of inflammatory bowel disease.

Florholmen J.

Scand J Gastroenterol. 2015 Jan;50(1):43-52. doi: 10.3109/00365521.2014.977943. Review.

PMID:
25523555
4.

Regulatory macrophages induced by infliximab are involved in healing in vivo and in vitro.

Vos AC, Wildenberg ME, Arijs I, Duijvestein M, Verhaar AP, de Hertogh G, Vermeire S, Rutgeerts P, van den Brink GR, Hommes DW.

Inflamm Bowel Dis. 2012 Mar;18(3):401-8. doi: 10.1002/ibd.21818. Epub 2011 Sep 20.

PMID:
21936028
5.

Optimizing Anti-TNF-α Therapy: Serum Levels of Infliximab and Adalimumab Are Associated With Mucosal Healing in Patients With Inflammatory Bowel Diseases.

Ungar B, Levy I, Yavne Y, Yavzori M, Picard O, Fudim E, Loebstein R, Chowers Y, Eliakim R, Kopylov U, Ben-Horin S.

Clin Gastroenterol Hepatol. 2016 Apr;14(4):550-557.e2. doi: 10.1016/j.cgh.2015.10.025. Epub 2015 Oct 29.

PMID:
26538204
6.

Mucosal healing with anti-TNF antibodies.

Chevaux JB, Vavricka SR, Rogler G, Lakatos PL, Schoepfer A, Peyrin-Biroulet L.

Digestion. 2012;86 Suppl 1:16-22. doi: 10.1159/000341957. Epub 2012 Oct 5. Review.

PMID:
23051722
7.

Mechanism of Action of Anti-TNF Therapy in Inflammatory Bowel Disease.

Levin AD, Wildenberg ME, van den Brink GR.

J Crohns Colitis. 2016 Aug;10(8):989-97. doi: 10.1093/ecco-jcc/jjw053. Epub 2016 Feb 19. Review.

PMID:
26896086
8.

Mucosal healing as a treatment for IBD?

Papi C, Aratari A.

Expert Rev Gastroenterol Hepatol. 2014 Jul;8(5):457-9. doi: 10.1586/17474124.2014.902302. Epub 2014 Mar 22.

PMID:
24654957
9.

Anti-TNF antibody therapy for inflammatory bowel disease during pregnancy: a clinical review.

El Mourabet M, El-Hachem S, Harrison JR, Binion DG.

Curr Drug Targets. 2010 Feb;11(2):234-41. Review.

PMID:
19916950
10.

Mucosal healing and anti TNFs in IBD.

van Assche G, Vermeire S, Rutgeerts P.

Curr Drug Targets. 2010 Feb;11(2):227-33.

PMID:
20210770
11.

Infliximab restores the dysfunctional matrix remodeling protein and growth factor gene expression in patients with inflammatory bowel disease.

de Bruyn M, Machiels K, Vandooren J, Lemmens B, Van Lommel L, Breynaert C, Van der Goten J, Staelens D, Billiet T, De Hertogh G, Ferrante M, Van Assche G, Vermeire S, Opdenakker G, Schuit F, Rutgeerts P, Arijs I.

Inflamm Bowel Dis. 2014 Feb;20(2):339-52. doi: 10.1097/01.MIB.0000438430.15553.90.

PMID:
24378596
12.

Early mucosal healing with infliximab is associated with improved long-term clinical outcomes in ulcerative colitis.

Colombel JF, Rutgeerts P, Reinisch W, Esser D, Wang Y, Lang Y, Marano CW, Strauss R, Oddens BJ, Feagan BG, Hanauer SB, Lichtenstein GR, Present D, Sands BE, Sandborn WJ.

Gastroenterology. 2011 Oct;141(4):1194-201. doi: 10.1053/j.gastro.2011.06.054. Epub 2011 Jun 30.

PMID:
21723220
13.

Clinical implications of mucosal healing for the management of IBD.

Pineton de Chambrun G, Peyrin-Biroulet L, Lémann M, Colombel JF.

Nat Rev Gastroenterol Hepatol. 2010 Jan;7(1):15-29. doi: 10.1038/nrgastro.2009.203. Epub 2009 Dec 1. Review.

PMID:
19949430
14.

Mucosal healing: impact on the natural course or therapeutic strategies.

Vatn MH.

Dig Dis. 2009;27(4):470-5. doi: 10.1159/000233285. Epub 2009 Nov 4. Review.

PMID:
19897962
15.

Endoscopic and histologic evidence of persistent mucosal healing and correlation with clinical improvement following sustained infliximab treatment for Crohn's disease.

Geboes K, Rutgeerts P, Opdenakker G, Olson A, Patel K, Wagner CL, Marano CW.

Curr Med Res Opin. 2005 Nov;21(11):1741-54.

PMID:
16307694
16.

Biologic therapy for inflammatory bowel disease.

Ardizzone S, Bianchi Porro G.

Drugs. 2005;65(16):2253-86. Review.

PMID:
16266194
17.

Review article: treatment algorithms to maximize remission and minimize corticosteroid dependence in patients with inflammatory bowel disease.

Panaccione R, Rutgeerts P, Sandborn WJ, Feagan B, Schreiber S, Ghosh S.

Aliment Pharmacol Ther. 2008 Sep 15;28(6):674-88. doi: 10.1111/j.1365-2036.2008.03753.x. Review.

18.

Antibodies against tumor necrosis factor (TNF) induce T-cell apoptosis in patients with inflammatory bowel diseases via TNF receptor 2 and intestinal CD14⁺ macrophages.

Atreya R, Zimmer M, Bartsch B, Waldner MJ, Atreya I, Neumann H, Hildner K, Hoffman A, Kiesslich R, Rink AD, Rau TT, Rose-John S, Kessler H, Schmidt J, Neurath MF.

Gastroenterology. 2011 Dec;141(6):2026-38. doi: 10.1053/j.gastro.2011.08.032. Epub 2011 Aug 27.

PMID:
21875498
19.

Apoptosis of regulatory T lymphocytes is increased in chronic inflammatory bowel disease and reversed by anti-TNFα treatment.

Veltkamp C, Anstaett M, Wahl K, Möller S, Gangl S, Bachmann O, Hardtke-Wolenski M, Länger F, Stremmel W, Manns MP, Schulze-Osthoff K, Bantel H.

Gut. 2011 Oct;60(10):1345-53. doi: 10.1136/gut.2010.217117. Epub 2011 Apr 1.

PMID:
21459928
20.

Endomicroscopy for assessing mucosal healing in patients with ulcerative colitis.

Gheorghe C, Cotruta B, Iacob R, Becheanu G, Dumbrava M, Gheorghe L.

J Gastrointestin Liver Dis. 2011 Dec;20(4):423-6.

Supplemental Content

Support Center